Bringing you the latest in science and tech from the Okinawa Institute of Science and Technology Graduate University.
…
continue reading
Kuva ois kiva on Suomen Valokuvataiteen museon podcast, jossa puhutaan kuvasta. Se katsoo valokuvaa aina myös laajemmin, avaten sen yhteiskunnallisen tai historiallisen kontekstin. Jokaisessa jaksossa kuunnellaan yksi kiehtova kuva ja kuullaan suomalaisen valokuvauksen mielenkiintoisimpia ihmisiä. Kuva ois kiva on vuoden museoviestintäteko finalisti 2023. Kaikki jakson kuvat ja muita linkkejä löytyvät Valokuvataiteen museon sivulta: https://www.valokuvataiteenmuseo.fi/fi/podcast Podcastin on ...
…
continue reading
Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.
…
continue reading
Tervetuloa kiipeilyn kovaan, kauniiseen, kitkalliseen ja kitkattomaan maailmaan. Me ollaan Monica ja Julia kaksi kiipeilijää, jotka etsivät vastauksia kiipeilymaailmasta ja sen ilmiöistä. Olemme kiipeilyn sanansaattajia, kysymysmestareita ja vastaus hunttereita. Ennen kaikkea haluamme kuitenkin kannustaa kaikkia elämään kiipeilyä juuri niin kuin itse haluaa. // IG: oiskobetaa. // www.oiskobetaa.fi
…
continue reading
Heitetään faktaa tiskiin ja höpötellään. Ja juodaan. Oispa viinii!
…
continue reading
The Basics of Cyber Security at the State of WV
…
continue reading
My daily podcast focuses on varying forms of intellectual, spiritual, and emotional food for thought. Every day except Friday, there is also an interview series with all different types of guests.
…
continue reading
retour à l’école et promenade à Auvers-sur-Oise Ce matin, Lisa est retournée à l’école. Hier soir, elle a préparé son cartable.— J’ai l’impression que c’est la rentrée, m’a-t-elle dit. Je me demande comment seront les autres élèves de la classe, comment sera ma maîtresse. Et puis, tout à coup, je me dis « Ah, mais je les connais déjà ! »
…
continue reading
Don't miss the latest episode of the OIS Retina Podcast, where we sit down with optometrist and ophthalmology researcher Brian Levy for an illuminating discussion on the future of eye care. In this episode, Brian takes us on a journey through his career, from his early days in vet school to his groundbreaking work at Presbyterian Medical Center, Ae…
…
continue reading
Kustantaja ja julkaisija Iina Esko keskustelee Valokuvataiteen museon museojohtajan, Anna-Kaisa Rastenbergerin kanssa valokuvataidekirjoista.Suomen Valokuvataiteen museo による
…
continue reading
1
How the serotonin system connects robots with mental health
28:41
28:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
28:41
In this latest episode of OIST’s podcast featuring researchers from the OIST Global Bioconvergence Center of Innovation, a center dedicated to promoting mental, physical, and environmental health based on the “One World, One Health” approach, OIST Podcaster in Residence, DJ Nick Luscombe spoke with Prof. Kenji Doya, leader of the Neural Computation…
…
continue reading
1
5 Mistakes to Avoid in Biotech Investor Pitch Decks
18:32
18:32
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
18:32
Tune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the dynamic world of biotech investor pitch decks with special guest Dr. Rob Rothman, Founding Partner of InFocus Capital Partners. Discover the top five mistakes to avoid when crafting your pitch deck and gain exclusive insights from Dr. Rothman's wealth o…
…
continue reading
Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to explore the latest advancements in presbyopia treatment strategies. Here's what you can expect from this insightful conversation: Insider Insights: Dr. Karpecki shares insider insights gleaned from his extensive clinical experience and research in the fiel…
…
continue reading
In the latest episode of the OIS Podcast, host Dr. Robert Rothman engages in a captivating dialogue with Dr. Prasad Sunkara, CEO of Eyegenex. Key points discussed in the episode: Prasad's multifaceted background spanning agricultural sciences to pharmaceuticals. Eyegenex's pioneering work in gene and peptide therapies for ophthalmic conditions. The…
…
continue reading
1
DJ Nick Luscombe, OIST Podcaster in Residence, introduces the Thematic Program of OIST TSVP
33:39
33:39
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
33:39
DJ Nick Luscombe, OIST Podcaster in Residence, checks out OIST's Visiting Program (TSVP). In this episode, he introduces the Thematic Programs that started last year as part of the TSVP. He talks to Dr. Samuel Ross, OIST researcher who is the scientific coordinator for the second the Thematic Program on "The Future of Response Diversity and Ecosyst…
…
continue reading
1
Making sci-fi healthcare with microfluidic devices and anti-senescence supplements
37:08
37:08
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
37:08
Embark on a journey into the future of healthcare with the fifth OIST podcast episode on the Global Bioconvergence Center of Innovation. DJ Nick Luscombe dives deep into groundbreaking research with Profs. Amy Shen and Keiko Kono, who are reshaping healthcare through microfluidic devices and anti-senescence supplements. From disease detection to fo…
…
continue reading
1
One World, One Health: The Global Bioconvergence Center of Innovation’s quest for sustainable solutions
19:52
19:52
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
19:52
In the latest episode of OIST’s Global Bioconvergence Center podcast series, DJ Nick Luscombe speaks to the team managing the Global Bioconvergence Center of Innovation at the Okinawa Institute of Science and Technology (OIST) about the highlights and challenges of pursuing the new center’s long-term objectives. The core team ensures the smooth run…
…
continue reading
1
Insights from Startup Leaders on Commercial Strategy and Funding
23:39
23:39
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
23:39
This panel discussion on startup commercial strategy explores key elements and insights from industry leaders, Paul Bresge, Aziz Mottiwala, Todd Pinkney, Cari Stone and Adam Szaronos, offering a comprehensive view of the journey from regulatory approval to commercialization. Beth Marsh, Lead of Sales and Marketing at Apellis, sets the stage by emph…
…
continue reading
1
Maximizing the Value of Your Board of Directors
22:04
22:04
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
22:04
OIS Podcast host Carey Powers speaks with Dr. Adrienne Graves and Dr. Barbara Wirostko on 'Maximizing the Value of Your Board of Director' live from OIS XIII. Dr. Graves and Dr. Wirostko share valuable insights on: * Building effective boards * Significance of diversity * CEO and board member communications * Navigating decision-making * Board dyna…
…
continue reading
1
Podcast Bonus: New Ratio interviews musician Aragaki Mutsumi
49:51
49:51
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
49:51
In this episode of the OIST Podcast, we introduce listeners to the latest episode of New Ratio, a podcast by OIST Podcaster in Residence DJ Nick Luscombe. In this interview and performance recorded at OIST in August of 2023, Okinawan musician ARAGAKI Mutsumi demonstrates how she combines Okinawan sanshin and traditional singing with environmental r…
…
continue reading
OIS Podcast による
…
continue reading
1
Revolutionizing Retina Care Beyond Injections
22:10
22:10
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
22:10
In this episode of the OIS Podcast, host Dr. Firas Rahhal, along with expert panelists, Dr. Robert Bhisitkul, Dr. Alan Franklin and Dr. Paul Karpecki at OIS XIII, takes listeners on a deep dive into the transformative landscape of oral therapies in retina treatment, challenging the conventional approach dominated by eye injections. Tune in as they …
…
continue reading
1
Revolutionizing Glaucoma Treatment and Innovation Insights
32:51
32:51
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
32:51
ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care. With a leadership team that has vast experience developing, designing, manufa…
…
continue reading
1
What listening to birds can teach us about our ecosystems
38:53
38:53
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
38:53
In the latest episode of our Global Bioconvergence Center of Innovation podcast series, DJ Nick Luscombe speaks with researchers from the OKEON Churamori Project, who use genomics, machine learning and acoustic monitoring to gain new insights into ecosystem health. Get more information at the Global Bioconvergence Center of Innovation.…
…
continue reading
1
Deep dive into marine science: Dynamic duo boosts coral reef research at OIST
30:18
30:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:18
In this second episode of the Global Bioconvergence Center of Innovation podcast series, DJ Nick Luscombe discusses coral reef research at OIST with Prof. Nori Satoh and Prof. Timothy Ravasi. From field trips to exotic places, to the valuable support of local Okinawans, it’s a fascinating journey!
…
continue reading
1
Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation
42:43
42:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
42:43
Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD. Explore the compelling journey from oncology to ophthal…
…
continue reading
Harrow isn’t a household name (yet), but eye care professionals have trusted its products for over a decade. The Nashville-based company produces Dexycu, an intraocular steroid; Iopidine for intraocular pressure control; and most recently, five Novartis products that Harrow acquired in December 2022. Rob Rothman, MD, caught up with Harrow founder a…
…
continue reading
Endogena Therapeutics has developed a novel approach to regenerative medicine that’s not only scientifically compelling, but practical. Endogena’s technology unlocks the body’s own stem cells for controlled tissue repair by small molecules. Its products use a dosing schedule that could move easily into the system already in place for intravitreal i…
…
continue reading
Delve into the first episode of a six-part series on the innovative research conducted at the Global Bioconvergence Center of Innovation. DJ Nick Luscombe, OIST Podcaster in Residence, talks to Prof. Tom Froese, leader of the Embodied Cognitive Science Unit at OIST. They discuss the center’s research on mental health and what mental well-being mean…
…
continue reading
Valokuvataiteilija Pentti Sammallahti ja Valokuvataiteen museon tuottaja Anna Reivilä keskustelevat filmikuvauksesta sekä pimiötyöskentelystä. Jakson juontaa Valokuvataiteen museon yleisötyön intendentti Erja Salo.Suomen Valokuvataiteen museo による
…
continue reading
1
The Bausch + Lomb Buzz, with Andrew Stewart and Yehia Hashad, MD
28:08
28:08
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
28:08
“You can see and feel a buzz within the company right now,” said Andrew Stewart, President, Global Pharmaceuticals and International Consumer, at Bausch + Lomb. Bausch + Lomb’s current momentum stems not only from new leadership, but also from recent collaborations, partnerships, and acquisitions. Stewart and Yehia Hashad, MD, Executive Vice Presid…
…
continue reading
1
C-Suite Quick Takes: OIS Goes Behind the Scenes with Four Emerging Biotech Companies
20:34
20:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
20:34
OIS Podcast host Carey Powers caught up with four ophthalmology execs and one principal investigator to talk about some of the most exciting developments in retina R&D. Her guests include: Houman David Hemmati, MD, PhD, Cofounder and Chief Medical Officer of Optigo Biotherapeutics Michael Tsipursky, MD, CEO and Cofounder of Revive Biotech Michael S…
…
continue reading
OIS Podcast host Carey Powers speaks with four CEOs from leading retina-focus companies to talk about all things innovation. Her guests include: • Kerrie Brady, BPharm, President and CEO of OcuTerra • Rich Small, CEO of NeuroTech Pharmaceuticals • Kester Nahen, PhD, CEO of Notal Vision • Brad Doerschuk, President and CEO of InFocus Clinical OcuTerr…
…
continue reading
1
DJ Nick Luscombe, OIST Podcaster in Residence, explores the Theoretical Sciences Visiting Program (TSVP)
44:25
44:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
44:25
DJ Nick Luscombe, OIST Podcaster in Residence, checks out OIST's Theoretical Sciences Visiting Program (TSVP). In this episode, he talks to Dr. Jonas Fischer, TSVP Academic Coordinator, and Prof. Simone Pigolotti to learn more about the program. He also interviews the guest researchers visiting OIST as part of the program and asks them about their …
…
continue reading
At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups. With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application, and adoption. Dr. Loewenstein is Head of the Department of Ophthalmology and Vice Dean at Tel Aviv Medi…
…
continue reading
Keith Valentine is the first and only visually impaired head of a national sight loss organization in the UK. As the President and CEO of Vision Foundation, London’s leading sight loss charity, Valentine guides an organization that provides services for blind and visually impaired people countrywide. He also has plans to increase the organization’s…
…
continue reading
Two recent drug approvals changed the game for ocular surface disease: Xdemvy (lotilaner ophthalmic solution) 0.25 percent (Tarsus Pharmaceuticals) for Demodex blepharitis, and Miebo (perfluorohexyloctane ophthalmic solution) from Bausch + Lomb and Novaliq for evaporative dry eye disease. On today’s podcast, two ocular surface disease experts talk …
…
continue reading
Yari Mitchell spent nearly 13 years with AcuFocus, an ophthalmic device company, before overseeing its acquisition by Bausch + Lomb. As head of Y Factor Consulting, she now helps innovators move their product from the lab to a funded company. Greg Kunst, President and CEO of Aurion Biotech, a cell therapy company, led the start-up to a $120 million…
…
continue reading
1
When Is the Right Time to Form a Spin-Out? With Wesley Jackson, PhD, Valitor
50:06
50:06
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
50:06
Wesley Jackson, PhD, spent years conducting post-doctoral research and writing grants, all the while setting the wheels in motion to launch Valitor. Valitor is developing VLTR-557 a long-lasting anti-VEGF. The technology platform, a multivalent polymer (MVP), is integral to VLTR-557. With Firas Rahhal, MD, Dr. Jackson shares why he stuck with the s…
…
continue reading